Status:
COMPLETED
SAFEty of Two Strategies of ICD Management at Implantation
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Ventricular Fibrillation
Ventricular Flutter
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this prospective observational study is to evaluate the safety, over a follow-up of 2 years, of two strategies, consisting in performing or not performing defibrillation testing(DT) during ...
Detailed Description
The standardized requirements for implantable cardioverter defibrillator (ICD) include defibrillation testing (DT), consisting in induction and termination of ventricular fibrillation (VF). An effecti...
Eligibility Criteria
Inclusion
- first implantation of ICD or CRT-D
- Patients undergoing upgrade to ICD or CRT-D from pacemaker
- Patients undergoing upgrade to CRT-D from CRT
- Age 18 or above, or legal age to give written informed consent
Exclusion
- Patients who do not give consent to treat their data.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
2120 Patients enrolled
Trial Details
Trial ID
NCT00661037
Start Date
March 1 2008
End Date
September 1 2011
Last Update
July 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedali del Tigullio, via Don Bobbio 25
Lavagna, Italy, 16033